Using regionally delivered autologous mesothelin-targeted CAR T cells in the treatment of malignant pleural disease

Social media as a tool for scientists

Tumour shrinkage with ipilimumab plus nivolumab in patients with neuroendocrine carcinoma

Importance of capacity development for African researchers

Increased stroke risk in childhood cancer survivors

KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases

Trends in breast cancer incidence and risk

MYSTIC: Developing biomarkers for metastatic NSCLC

TATTON: Updated results for patients with EGFR-mutant NSCLC

Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients with advanced solid tumours

Immune checkpoint inhibitor combination efficacious for patients with high-grade neuroendocrine carcinoma

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma